
Colabra is an R&D cloud platform designed to manage biopharma collaborations. It centralizes siloed data and conversations, ensuring continuity through personnel changes and keeping stakeholders informed. The platform offers features for alliance management, project management, knowledge management (electronic lab notebook), and an AI Copilot for decision-making. Colabra aims to increase research velocity by consolidating tools, providing over 100 integrations, and offering advanced features like custom policies, full-text search, and AI-powered summarization and data retrieval. It is built for teams frustrated with existing tools like SharePoint, Benchling, and Jira, positioning itself as a single source of truth for research data, notes, and communications. Colabra is SOC 2 Type 2 certified and GxP aligned, ensuring security and compliance.

Colabra is an R&D cloud platform designed to manage biopharma collaborations. It centralizes siloed data and conversations, ensuring continuity through personnel changes and keeping stakeholders informed. The platform offers features for alliance management, project management, knowledge management (electronic lab notebook), and an AI Copilot for decision-making. Colabra aims to increase research velocity by consolidating tools, providing over 100 integrations, and offering advanced features like custom policies, full-text search, and AI-powered summarization and data retrieval. It is built for teams frustrated with existing tools like SharePoint, Benchling, and Jira, positioning itself as a single source of truth for research data, notes, and communications. Colabra is SOC 2 Type 2 certified and GxP aligned, ensuring security and compliance.
Product: Cloud R&D collaboration platform and electronic lab notebook with AI Copilot and 100+ integrations
Security & Compliance: SOC 2 Type II certified and GxP aligned
Team size: 9 employees
Funding (reported): $3,050,000 total disclosed
Founders: Aoi Senju and Philip Seifi
Scientific R&D collaboration, data integration, and experiment documentation for biopharma and research teams.
Life sciences / R&D software
3050000.00
Last disclosed funding date and total amount reported in company data
$1,500,000
Company announced an oversubscribed $1.5M round (per company blog)
“Backed by investors including Village Global, Builders VC, BoxOne Ventures, Inovia Capital, FoundersX, Longtail Health Ventures, On Deck, Jude Gomila”